Morepen Laboratories Ltd buy melinda
Start price
11.09.17
/
50%
?0.23
Target price
14.11.17
€0.30
Performance (%)
11.90%
End price
14.11.17
€0.26
Summary
This prediction ended on 14.11.17 with a price of €0.26. The BUY prediction by melinda finished with a performance of 11.90%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Morepen Laboratories Ltd | - | - | - | - |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
Comments by melinda for this prediction
In the thread Morepen Laboratories Ltd diskutieren
LABOR
Morepen Laboratories of India
11. September (Reuters) - Morepen Laboratories Ltd: Juni - Quartal Nettogewinn von 19,6 Millionen Rupien verglichen mit einem Gewinn von 29,8 Millionen Rupien vor einem Jahr. Die Gesamterträge der Juni - Quartal 1,24 Milliarden Rupien gegen 1,21 Milliarden Rupien vor einem Jahr.
(Vom Mitglied beendet)


